SCHEMBL6139747

SCHEMBL6139747

Cc1ccsc1-c1cccc(C(=O)O)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMO O15229 2/20 0.51
GAA P10253 3/20 0.48
MEN1 O00255 2/20 0.48
MAPT P10636 2/20 0.48
KMT2A Q03164 2/20 0.48
NPC1 O15118 1/20 0.48
NFKB1 P19838 1/20 0.48
RAB9A P51151 1/20 0.48
NFKB2 Q00653 1/20 0.48
RELA Q04206 1/20 0.48
PAX8 Q06710 1/20 0.48
SMN1; SMN2 Q16637 1/20 0.48
RXRA P19793 2/20 0.46
RXRB P28702 2/20 0.46
AKR1C3 P42330 1/20 0.46
AKR1C2 P52895 1/20 0.46
TBXA2R P21731 1/20 0.46
PTGER1 P34995 1/20 0.46
CYP2A6 P11509 2/20 0.45
CYP2E1 P05181 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL58532 0.81 NR1H4 (0.58) MAPTNPC1RAB9ANR1H4CA2
SCHEMBL7830647 0.77 KMO (0.51) KMOGAAMEN1MAPTKMT2A
SCHEMBL19861976 0.77 MEN1 (0.43) GAAMEN1MAPTKMT2ANPC1
SCHEMBL7940868 0.75 CYP2A6 (0.58) MEN1KMT2ANPC1RAB9ASMN1; SMN2
SCHEMBL28080232 0.75 MEN1 (0.49) MEN1MAPTKMT2ANPC1RAB9A
SCHEMBL19125493 0.75 TBXA2R (0.49) KMOGAAMEN1MAPTKMT2A
SCHEMBL1821918 0.74 CYP2A6 (0.60) MEN1KMT2ACYP2A6CYP2E1CYP3A4
SCHEMBL29904709 0.74 KMO (0.86) KMOGAARXRARXRBCYP2C9
SCHEMBL30725957 0.74 KMO (0.86) KMOGAARXRARXRBCYP2C9
SCHEMBL71238 0.74 KMO (0.86) KMOGAARXRARXRBCYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1503980-A2 SUBSTITUTED HYDROXYETHYLAMINES Elan Pharmaceuticals, Inc. (US) 2005-02-09 EP disclosed
WO-2003072535-A2 SUBSTITUTED HYDROXYETHYLAMINES ELAN PHARMACEUTICALS, INC. (US) 2003-09-04 WO disclosed
CN-1070173-C Benzoylguanidine derivatives as medicaments FUJISAWA PHARMACEUTICAL CO (JP) 2001-08-29 CN disclosed
US-5968985-A INHIBITORS OF SODIUM ION/HYDROGEN ION EXCHANGE IN CELLS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-10-19 US disclosed
CN-1158606-A Benzoylguanidine derivatives as medicaments FUJISAWA PHARMACEUTICAL CO (JP) 1997-09-03 CN disclosed
EP-0773927-A2 BENZOYLGUANIDINE DERIVATIVES AS MEDICAMENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-05-21 EP disclosed
WO-1996004241-A2 BENZOYLGUANIDINE DERIVATIVES AS MEDICAMENTS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-02-15 WO disclosed